InvestorsHub Logo
Followers 8
Posts 1857
Boards Moderated 0
Alias Born 07/31/2021

Re: JPG77 post# 196825

Tuesday, 12/14/2021 9:29:36 PM

Tuesday, December 14, 2021 9:29:36 PM

Post# of 233035
This is from Cytodyn's own recent press release, under the "About Cytodyn" section towards the end:

CytoDyn has already completed a Phase 2 and Phase 3 trial for mild-to-moderate and severe-to-critical COVID-19 patients, respectively, for which CytoDyn did not meet its primary or secondary endpoints, except for the secondary endpoint in the critically ill subpopulation.

Recent CYDY PR
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News